INCY · Incyte Corp
United States · RS rating 75 · As of 2026-11-03
| Price | 117.59 USD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 66 / 62 / 72 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 46 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -30.8% |
| Sales growth Q/Q | +10.3% |
| Distance from 52-week high | +9.5% |
| Market cap (USD) | $19.0B |